pentoxifylline has been researched along with Chronic Hepatitis C in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Metwally, AH | 1 |
| Khan, F | 1 |
| Peltekian, KM | 1 |
| Peterson, TC | 1 |
| Hemsworth-Peterson, TC | 1 |
| Gutierrez-Reyes, G | 1 |
| Lopez-Ortal, P | 1 |
| Sixtos, S | 1 |
| Cruz, S | 1 |
| Ramirez-Iglesias, MT | 1 |
| Gutierrez-Ruiz, MC | 1 |
| Sanchez-Avila, F | 1 |
| Roldan, E | 1 |
| Vargas-Vorackova, F | 1 |
| Kershenobich, D | 1 |
| Koczorek, M | 1 |
5 other studies available for pentoxifylline and Chronic Hepatitis C
| Article | Year |
|---|---|
Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C.
Topics: Antiviral Agents; Cardiovascular Diseases; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver C | 2014 |
Effect of interferon-alpha, ribavirin, pentoxifylline, and interleukin-18 antibody on hepatitis C sera-stimulated hepatic stellate cell proliferation.
Topics: Animals; Antibodies, Monoclonal; Cell Proliferation; Cells, Cultured; Hepacivirus; Hepatic Stellate | 2008 |
The mechanism behind the novel fibrosis recently described in NASH in HEPATOLOGY 2011 and elsewhere.
Topics: Cohort Studies; Fatty Liver; Female; Forecasting; Gastroenterology; Hepatitis C, Chronic; Humans; Li | 2012 |
Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C.
Topics: Adult; Cytokines; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Inflammation Mediators; Interfe | 2006 |
[Chronic liver diseases. The nihilism has gone].
Topics: Amantadine; Antioxidants; Antiviral Agents; Chronic Disease; Dipeptides; Drug Therapy, Combination; | 2001 |